CNC
CENTENE CORP
Company overview
- Market capitalization
- $30.89B
- Employees
- 61,000
- Latest publication
- 2026-09-29
About CENTENE CORP
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q2 20232023-06-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 53,579,000,000USD | 49,944,000,000USD | 46,620,000,000USD | 42,023,000,000USD | 39,836,000,000USD | 40,407,000,000USD | 37,608,000,000USD | 38,889,000,000USD |
| Cost Of Revenue | 729,000,000USD | 39,005,000,000USD | 41,418,000,000USD | 37,988,000,000USD | 35,407,000,000USD | 35,762,000,000USD | 33,078,000,000USD | 34,315,000,000USD |
| Gross Profit | 4,617,000,000USD | 10,939,000,000USD | 5,202,000,000USD | 4,035,000,000USD | 4,429,000,000USD | 4,645,000,000USD | 4,530,000,000USD | 4,574,000,000USD |
| Selling General Administrative | 3,103,000,000USD | 3,397,000,000USD | 3,353,000,000USD | 3,057,000,000USD | 2,894,000,000USD | 3,218,000,000USD | 3,016,000,000USD | 3,011,000,000USD |
| Other Operating Expenses | 12,623,000,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 3,419,000,000USD | 9,078,000,000USD | 3,668,000,000USD | 3,370,000,000USD | 3,200,000,000USD | 3,539,000,000USD | 3,359,000,000USD | 3,356,000,000USD |
| Operating Income | 1,198,000,000USD | 1,861,000,000USD | 1,534,000,000USD | 665,000,000USD | 1,229,000,000USD | 1,106,000,000USD | 1,171,000,000USD | 1,218,000,000USD |
| Total Other Income Expense Net | 288,000,000USD | 238,000,000USD | 212,000,000USD | 256,000,000USD | 287,000,000USD | 367,000,000USD | 244,000,000USD | 173,000,000USD |
| Interest Expense | 153,000,000USD | 164,000,000USD | 170,000,000USD | 176,000,000USD | 176,000,000USD | 178,000,000USD | 181,000,000USD | 180,000,000USD |
| Income Before Tax | 1,486,000,000USD | 2,099,000,000USD | 1,746,000,000USD | 921,000,000USD | 1,516,000,000USD | 1,473,000,000USD | 1,415,000,000USD | 1,391,000,000USD |
| Income Tax Expense | 399,000,000USD | 560,000,000USD | 432,000,000USD | 211,000,000USD | 370,000,000USD | 315,000,000USD | 360,000,000USD | 261,000,000USD |
| Net Income | 1,087,000,000USD | 1,541,000,000USD | 1,311,000,000USD | 713,000,000USD | 1,146,000,000USD | 1,163,000,000USD | 1,058,000,000USD | 1,130,000,000USD |
| Minority Interest | -4,000,000USD | 2,000,000USD | -3,000,000USD | 3,000,000USD | 0USD | 5,000,000USD | -3,000,000USD | 0USD |
| Net Income Applicable To Common Shares | 1,091,000,000USD | — | 1,311,000,000USD | 713,000,000USD | — | — | 1,058,000,000USD | 1,130,000,000USD |
| Unclassified Operating Expenses | — | 5,681,000,000USD | 315,000,000USD | 313,000,000USD | 306,000,000USD | 321,000,000USD | 343,000,000USD | 345,000,000USD |
| Net Interest Income | — | -164,000,000USD | -170,000,000USD | -176,000,000USD | -176,000,000USD | -178,000,000USD | -181,000,000USD | -180,000,000USD |
| Tax Provision | — | 560,000,000USD | 432,000,000USD | 211,000,000USD | 370,000,000USD | 315,000,000USD | 360,000,000USD | 261,000,000USD |
| Net Income From Continuing Ops | — | 1,539,000,000USD | 1,314,000,000USD | 710,000,000USD | 1,146,000,000USD | 1,158,000,000USD | 1,055,000,000USD | 1,130,000,000USD |
| Ebit | — | 2,263,000,000USD | 1,916,000,000USD | 1,097,000,000USD | 1,692,000,000USD | 1,651,000,000USD | 1,596,000,000USD | 1,571,000,000USD |
| Ebitda | — | 2,563,000,000USD | 2,231,000,000USD | 1,410,000,000USD | 1,998,000,000USD | 1,959,000,000USD | 1,921,000,000USD | 1,896,000,000USD |
| Depreciation And Amortization | — | 300,000,000USD | 315,000,000USD | 313,000,000USD | 306,000,000USD | 308,000,000USD | 325,000,000USD | 325,000,000USD |
| Reconciled Depreciation | — | 300,000,000USD | 314,000,000USD | 313,000,000USD | 306,000,000USD | 308,000,000USD | 325,000,000USD | 346,000,000USD |
| Interest Income | — | — | 170,000,000USD | 176,000,000USD | — | — | 181,000,000USD | 180,000,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 425,000,000USD | 353,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 163,071,000,000USD | 153,999,000,000USD | 144,547,000,000USD | 125,982,000,000USD | 111,115,000,000USD | 74,639,000,000USD | 60,116,000,000USD | 40,607,000,000USD |
| Cost Of Revenue | 146,242,000,000USD | 122,458,000,000USD | 127,891,000,000USD | 111,783,000,000USD | 95,899,000,000USD | 65,796,000,000USD | 51,695,000,000USD | 35,063,000,000USD |
| Gross Profit | 16,829,000,000USD | 31,541,000,000USD | 16,656,000,000USD | 14,199,000,000USD | 15,216,000,000USD | 8,843,000,000USD | 8,421,000,000USD | 5,544,000,000USD |
| Selling General Administrative | 12,400,000,000USD | 12,273,000,000USD | 20,919,000,000USD | 10,166,000,000USD | 11,343,000,000USD | 6,533,000,000USD | 6,752,000,000USD | 4,134,000,000USD |
| Unclassified Operating Expenses | 1,254,000,000USD | 16,338,000,000USD | -5,581,000,000USD | 1,684,000,000USD | 791,000,000USD | 529,000,000USD | 211,000,000USD | 147,000,000USD |
| Total Operating Expenses | 13,654,000,000USD | 28,611,000,000USD | 15,338,000,000USD | 12,415,000,000USD | 12,134,000,000USD | 7,062,000,000USD | 6,963,000,000USD | 4,281,000,000USD |
| Operating Income | 3,175,000,000USD | 2,930,000,000USD | 1,318,000,000USD | 1,784,000,000USD | 3,082,000,000USD | 1,781,000,000USD | 1,458,000,000USD | 1,263,000,000USD |
| Interest Income | 702,000,000USD | 725,000,000USD | 665,000,000USD | 665,000,000USD | 728,000,000USD | 412,000,000USD | 343,000,000USD | 217,000,000USD |
| Interest Expense | 702,000,000USD | 725,000,000USD | 665,000,000USD | 665,000,000USD | 728,000,000USD | 412,000,000USD | 343,000,000USD | 217,000,000USD |
| Net Interest Income | -702,000,000USD | -716,000,000USD | -665,000,000USD | -665,000,000USD | -728,000,000USD | -412,000,000USD | -343,000,000USD | -217,000,000USD |
| Income Before Tax | 4,257,000,000USD | 3,598,000,000USD | 1,962,000,000USD | 1,813,000,000USD | 2,773,000,000USD | 1,782,000,000USD | 1,368,000,000USD | 1,160,000,000USD |
| Income Tax Expense | 963,000,000USD | 899,000,000USD | 760,000,000USD | 477,000,000USD | 979,000,000USD | 473,000,000USD | 474,000,000USD | 599,000,000USD |
| Tax Provision | 963,000,000USD | 1,174,000,000USD | 760,000,000USD | 477,000,000USD | 979,000,000USD | 473,000,000USD | 474,000,000USD | 599,000,000USD |
| Net Income | 3,305,000,000USD | 2,702,000,000USD | 1,202,000,000USD | 1,347,000,000USD | 1,808,000,000USD | 1,321,000,000USD | 900,000,000USD | 562,000,000USD |
| Net Income From Continuing Ops | 3,294,000,000USD | 2,441,000,000USD | 1,202,000,000USD | 1,336,000,000USD | 1,794,000,000USD | 2,255,000,000USD | 894,000,000USD | 558,000,000USD |
| Ebit | 4,959,000,000USD | 2,930,000,000USD | 2,627,000,000USD | 2,478,000,000USD | 3,501,000,000USD | 2,194,000,000USD | 1,711,000,000USD | 1,377,000,000USD |
| Ebitda | 6,200,000,000USD | 2,930,000,000USD | 4,058,000,000USD | 3,813,000,000USD | 4,760,000,000USD | 2,837,000,000USD | 2,206,000,000USD | 1,655,000,000USD |
| Depreciation And Amortization | 1,241,000,000USD | 1,293,000,000USD | 1,431,000,000USD | 1,335,000,000USD | 1,259,000,000USD | 643,000,000USD | 495,000,000USD | 278,000,000USD |
| Reconciled Depreciation | 1,241,000,000USD | 1,452,000,000USD | 1,553,000,000USD | 1,476,000,000USD | 1,259,000,000USD | 643,000,000USD | 495,000,000USD | — |
| Total Other Income Expense Net | 1,082,000,000USD | 668,000,000USD | 644,000,000USD | 29,000,000USD | -309,000,000USD | 1,000,000USD | -90,000,000USD | -103,000,000USD |
| Minority Interest | 11,000,000USD | 3,000,000USD | 3,000,000USD | 11,000,000USD | -14,000,000USD | -12,000,000USD | -6,000,000USD | -1,000,000USD |
| Net Income Applicable To Common Shares | 3,305,000,000USD | 2,702,000,000USD | 1,202,000,000USD | 1,347,000,000USD | 1,808,000,000USD | 1,321,000,000USD | 900,000,000USD | 562,000,000USD |
| Non Operating Income Net Other | — | — | 1,279,000,000USD | 819,000,000USD | 480,000,000USD | 413,000,000USD | 253,000,000USD | 114,000,000USD |
| Selling And Marketing Expenses | — | — | — | 565,000,000USD | — | — | — | — |
| Research Development | — | — | — | — | — | — | 0USD | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 3,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 83,012,000,000USD | 81,175,000,000USD | 77,661,000,000USD | 82,087,000,000USD | 86,395,000,000USD | 87,044,000,000USD | 82,445,000,000USD | 82,351,000,000USD |
| Cash And Equivalents | 24,151,000,000USD | — | 17,888,000,000USD | 17,058,000,000USD | 14,513,000,000USD | 14,815,000,000USD | 14,063,000,000USD | 14,577,000,000USD |
| Cash And Short Term Investments | 27,057,000,000USD | 23,741,000,000USD | 17,888,000,000USD | 19,237,000,000USD | 17,281,000,000USD | 17,287,000,000USD | 16,685,000,000USD | 17,569,000,000USD |
| Short Term Investments | 2,906,000,000USD | 2,477,000,000USD | 2,432,000,000USD | 2,179,000,000USD | 2,768,000,000USD | 2,472,000,000USD | 2,622,000,000USD | 2,992,000,000USD |
| Long Term Investments | 16,302,000,000USD | 16,599,000,000USD | 17,035,000,000USD | 18,180,000,000USD | 18,797,000,000USD | 18,268,000,000USD | 17,429,000,000USD | 17,691,000,000USD |
| Total Current Assets | 46,685,000,000USD | 44,989,000,000USD | 35,993,000,000USD | 44,062,000,000USD | 40,389,000,000USD | 41,288,000,000USD | 37,999,000,000USD | 37,409,000,000USD |
| Other Current Assets | 1,552,000,000USD | 1,822,000,000USD | 20,050,000,000USD | 1,716,000,000USD | 1,556,000,000USD | 1,565,000,000USD | 1,601,000,000USD | 1,559,000,000USD |
| Other Non Current Assets | 1,370,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 60,355,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 40,759,000,000USD | 40,045,000,000USD | 21,476,000,000USD | 40,630,000,000USD | 36,786,000,000USD | 37,143,000,000USD | 34,261,000,000USD | 34,061,000,000USD |
| Other Non Current Liabilities | 2,810,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 22,562,000,000USD | 21,427,000,000USD | 19,953,000,000USD | 20,948,000,000USD | 27,406,000,000USD | 27,916,000,000USD | 26,410,000,000USD | 27,307,000,000USD |
| Total Equity Including Noncontrolling Interest | 22,657,000,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 150,000,000USD | 63,000,000USD | 50,000,000USD | 38,000,000USD | 25,000,000USD | 12,000,000USD | 110,000,000USD | 111,000,000USD |
| Long Term Debt | 16,030,000,000USD | 16,308,000,000USD | 17,351,000,000USD | 17,545,000,000USD | 17,552,000,000USD | 18,308,000,000USD | 18,423,000,000USD | 17,494,000,000USD |
| Deferred Revenue | 706,000,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,130,000,000USD | 2,090,000,000USD | 2,354,000,000USD | 2,161,000,000USD | 2,122,000,000USD | 2,044,000,000USD | 2,426,000,000USD | 2,042,000,000USD |
| Goodwill | 10,835,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 4,203,000,000USD | 4,364,000,000USD | 4,530,000,000USD | 4,840,000,000USD | 5,010,000,000USD | 5,236,000,000USD | 5,409,000,000USD | 5,582,000,000USD |
| Accounts Payable | 17,965,000,000USD | 16,832,000,000USD | 20,544,000,000USD | 16,875,000,000USD | 13,520,000,000USD | 13,948,000,000USD | 13,016,000,000USD | 13,338,000,000USD |
| Common Stock | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD |
| Retained Earnings | 11,306,000,000USD | 10,215,000,000USD | 8,674,000,000USD | 9,775,000,000USD | 16,406,000,000USD | 16,659,000,000USD | 15,348,000,000USD | 15,065,000,000USD |
| Accumulated Other Comprehensive Income | -194,000,000USD | -171,000,000USD | -58,000,000USD | -100,000,000USD | -231,000,000USD | -337,000,000USD | -504,000,000USD | -226,000,000USD |
| Total Liab | — | 59,648,000,000USD | 57,605,000,000USD | 61,032,000,000USD | 58,892,000,000USD | 59,025,000,000USD | 55,935,000,000USD | 54,942,000,000USD |
| Other Current Liab | — | 22,197,000,000USD | -50,000,000USD | 23,061,000,000USD | 22,559,000,000USD | 22,314,000,000USD | 20,316,000,000USD | 19,954,000,000USD |
| Capital Stock | — | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD |
| Good Will | — | 10,835,000,000USD | 10,835,000,000USD | 10,835,000,000USD | 17,558,000,000USD | 17,558,000,000USD | 17,558,000,000USD | 17,558,000,000USD |
| Cash | — | 21,264,000,000USD | 17,888,000,000USD | 17,058,000,000USD | 14,513,000,000USD | 14,815,000,000USD | 14,063,000,000USD | 14,577,000,000USD |
| Current Deferred Revenue | — | 953,000,000USD | 736,000,000USD | 656,000,000USD | 682,000,000USD | 869,000,000USD | 661,000,000USD | 658,000,000USD |
| Net Debt | — | -4,893,000,000USD | 889,000,000USD | 525,000,000USD | 3,064,000,000USD | 3,505,000,000USD | 5,366,000,000USD | 3,028,000,000USD |
| Short Term Debt | — | 63,000,000USD | 196,000,000USD | 38,000,000USD | 25,000,000USD | 12,000,000USD | 268,000,000USD | 111,000,000USD |
| Short Long Term Debt Total | — | 16,371,000,000USD | 18,777,000,000USD | 17,583,000,000USD | 17,577,000,000USD | 18,320,000,000USD | 19,429,000,000USD | 17,605,000,000USD |
| Net Receivables | — | 19,426,000,000USD | 18,105,000,000USD | 23,109,000,000USD | 21,552,000,000USD | 22,436,000,000USD | 19,713,000,000USD | 18,281,000,000USD |
| Common Stock Shares Outstanding | — | 495,591,000shares | 491,071,428shares | 491,141,000shares | 493,548,000shares | 498,180,000shares | 501,978,000shares | 523,542,000shares |
| Non Current Assets Total | — | 36,186,000,000USD | 41,668,000,000USD | 38,025,000,000USD | 46,006,000,000USD | 45,756,000,000USD | 44,446,000,000USD | 44,942,000,000USD |
| Non Current Liabilities Total | — | 19,603,000,000USD | 36,129,000,000USD | 20,402,000,000USD | 22,106,000,000USD | 21,882,000,000USD | 21,674,000,000USD | 20,881,000,000USD |
| Non Current Liabilities Other | — | 2,551,000,000USD | 1,196,000,000USD | 2,047,000,000USD | 3,903,000,000USD | 2,866,000,000USD | 1,829,000,000USD | 2,618,000,000USD |
| Non Currrent Assets Other | — | 2,298,000,000USD | 2,156,000,000USD | 2,009,000,000USD | 2,519,000,000USD | 2,650,000,000USD | 1,624,000,000USD | 2,069,000,000USD |
| Net Working Capital | — | 4,944,000,000USD | 3,674,000,000USD | 3,432,000,000USD | 3,603,000,000USD | 4,145,000,000USD | 3,738,000,000USD | 3,348,000,000USD |
| Unclassified Non Current Liabilities | — | 744,000,000USD | 17,582,000,000USD | 810,000,000USD | 651,000,000USD | 708,000,000USD | 1,422,000,000USD | 769,000,000USD |
| Unclassified Equity | — | 11,381,000,000USD | 11,335,000,000USD | 11,271,000,000USD | 11,229,000,000USD | 11,592,000,000USD | 11,564,000,000USD | 12,466,000,000USD |
| Other Assets | — | — | 1,940,000,000USD | 2,009,000,000USD | 86,395,000,000USD | 2,650,000,000USD | 1,624,000,000USD | 2,069,000,000USD |
| Property Plant Equipment Gross | — | — | 4,586,000,000USD | — | — | — | 5,229,000,000USD | — |
| Unclassified Current Assets | — | — | -22,482,000,000USD | — | — | — | — | — |
| Unclassified Non Current Assets | — | — | 2,818,000,000USD | -2,009,000,000USD | -86,395,000,000USD | -2,650,000,000USD | -1,624,000,000USD | -2,069,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 77,661,000,000USD | 82,445,000,000USD | 84,641,000,000USD | 76,870,000,000USD | 78,375,000,000USD | 68,719,000,000USD | 40,994,000,000USD | 30,901,000,000USD |
| Intangible Assets | 4,530,000,000USD | 5,409,000,000USD | 6,101,000,000USD | 6,911,000,000USD | 7,824,000,000USD | 8,388,000,000USD | 2,063,000,000USD | 2,239,000,000USD |
| Other Current Assets | 20,050,000,000USD | 1,601,000,000USD | 5,572,000,000USD | 2,461,000,000USD | 1,602,000,000USD | 1,317,000,000USD | 1,090,000,000USD | 784,000,000USD |
| Total Liab | 57,605,000,000USD | 55,935,000,000USD | 58,685,000,000USD | 52,633,000,000USD | 51,353,000,000USD | 42,757,000,000USD | 28,302,000,000USD | 19,878,000,000USD |
| Total Stockholder Equity | 19,953,000,000USD | 26,410,000,000USD | 25,840,000,000USD | 24,057,000,000USD | 26,795,000,000USD | 25,773,000,000USD | 12,551,000,000USD | 10,917,000,000USD |
| Other Current Liab | -50,000,000USD | 20,316,000,000USD | 19,462,000,000USD | 18,379,000,000USD | 16,571,000,000USD | 13,692,000,000USD | 8,297,000,000USD | 7,497,000,000USD |
| Common Stock | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 0USD | 7,449,000,000USD |
| Capital Stock | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 1,000,000USD | 0USD | 0USD |
| Retained Earnings | 8,674,000,000USD | 15,348,000,000USD | 12,043,000,000USD | 9,341,000,000USD | 8,139,000,000USD | 6,792,000,000USD | 4,984,000,000USD | 3,663,000,000USD |
| Good Will | 10,835,000,000USD | 17,558,000,000USD | 17,558,000,000USD | 18,812,000,000USD | 19,771,000,000USD | 18,652,000,000USD | 6,863,000,000USD | 7,015,000,000USD |
| Other Assets | 1,940,000,000USD | 1,624,000,000USD | 1,525,000,000USD | 1,217,000,000USD | 4,849,000,000USD | 2,659,000,000USD | 1,236,000,000USD | 1,082,000,000USD |
| Cash | 17,888,000,000USD | 14,063,000,000USD | 17,193,000,000USD | 12,074,000,000USD | 13,118,000,000USD | 10,800,000,000USD | 12,123,000,000USD | 5,342,000,000USD |
| Cash And Equivalents | 17,888,000,000USD | 14,063,000,000USD | 17,193,000,000USD | 12,074,000,000USD | 13,118,000,000USD | 10,800,000,000USD | 12,123,000,000USD | 5,342,000,000USD |
| Cash And Short Term Investments | 17,888,000,000USD | 16,685,000,000USD | 19,652,000,000USD | 14,395,000,000USD | 14,657,000,000USD | 12,380,000,000USD | 12,986,000,000USD | 6,064,000,000USD |
| Total Current Assets | 35,993,000,000USD | 37,999,000,000USD | 40,756,000,000USD | 30,128,000,000USD | 28,497,000,000USD | 23,393,000,000USD | 20,323,000,000USD | 11,998,000,000USD |
| Total Current Liabilities | 21,476,000,000USD | 34,261,000,000USD | 36,716,000,000USD | 28,464,000,000USD | 25,765,000,000USD | 21,585,000,000USD | 12,932,000,000USD | 11,971,000,000USD |
| Current Deferred Revenue | 736,000,000USD | 661,000,000USD | 715,000,000USD | 478,000,000USD | 434,000,000USD | 523,000,000USD | 383,000,000USD | 385,000,000USD |
| Net Debt | 889,000,000USD | 5,366,000,000USD | 1,684,000,000USD | 9,259,000,000USD | 9,543,000,000USD | 7,517,000,000USD | 2,386,000,000USD | 1,344,000,000USD |
| Short Term Debt | 196,000,000USD | 268,000,000USD | 287,000,000USD | 262,000,000USD | 471,000,000USD | 301,000,000USD | 249,000,000USD | 38,000,000USD |
| Short Long Term Debt | 50,000,000USD | 110,000,000USD | 119,000,000USD | 82,000,000USD | 267,000,000USD | 97,000,000USD | 88,000,000USD | 38,000,000USD |
| Short Long Term Debt Total | 18,777,000,000USD | 19,429,000,000USD | 18,877,000,000USD | 21,333,000,000USD | 22,661,000,000USD | 18,317,000,000USD | 14,509,000,000USD | 6,686,000,000USD |
| Long Term Debt | 17,351,000,000USD | 18,423,000,000USD | 17,710,000,000USD | 17,938,000,000USD | 18,571,000,000USD | 16,682,000,000USD | 13,638,000,000USD | 6,648,000,000USD |
| Long Term Investments | 17,035,000,000USD | 17,429,000,000USD | 16,286,000,000USD | 14,684,000,000USD | 14,043,000,000USD | 12,853,000,000USD | 7,717,000,000USD | 6,861,000,000USD |
| Short Term Investments | 2,432,000,000USD | 2,622,000,000USD | 2,459,000,000USD | 2,321,000,000USD | 1,539,000,000USD | 1,580,000,000USD | 863,000,000USD | 722,000,000USD |
| Net Receivables | 18,105,000,000USD | 19,713,000,000USD | 15,532,000,000USD | 13,272,000,000USD | 12,238,000,000USD | 9,696,000,000USD | 6,247,000,000USD | 5,150,000,000USD |
| Accounts Payable | 20,544,000,000USD | 13,016,000,000USD | 16,252,000,000USD | 9,345,000,000USD | 8,289,000,000USD | 7,069,000,000USD | 4,003,000,000USD | 4,051,000,000USD |
| Property Plant Equipment Net | 2,354,000,000USD | 2,426,000,000USD | 2,415,000,000USD | 4,986,000,000USD | 6,957,000,000USD | 2,774,000,000USD | 2,782,000,000USD | 1,706,000,000USD |
| Property Plant Equipment Gross | 4,586,000,000USD | 5,229,000,000USD | 4,419,000,000USD | 2,432,000,000USD | 3,391,000,000USD | 4,085,000,000USD | 2,121,000,000USD | 1,706,000,000USD |
| Accumulated Other Comprehensive Income | -58,000,000USD | -504,000,000USD | -652,000,000USD | -1,132,000,000USD | 77,000,000USD | 337,000,000USD | 134,000,000USD | -56,000,000USD |
| Common Stock Shares Outstanding | 491,071,000shares | 523,744,000shares | 545,704,000shares | 582,040,000shares | 590,516,000shares | 579,135,000shares | 420,409,000shares | 398,506,000shares |
| Non Current Assets Total | 41,668,000,000USD | 44,446,000,000USD | 43,885,000,000USD | 46,742,000,000USD | 49,878,000,000USD | 45,326,000,000USD | 20,671,000,000USD | 18,903,000,000USD |
| Non Current Liabilities Total | 36,129,000,000USD | 21,674,000,000USD | 21,969,000,000USD | 24,169,000,000USD | 25,588,000,000USD | 21,172,000,000USD | 15,370,000,000USD | 7,907,000,000USD |
| Non Current Liabilities Other | 1,196,000,000USD | 1,829,000,000USD | 3,618,000,000USD | 5,616,000,000USD | 5,610,000,000USD | 2,956,000,000USD | 1,732,000,000USD | 1,259,000,000USD |
| Non Currrent Assets Other | 2,156,000,000USD | 1,624,000,000USD | 1,525,000,000USD | 1,349,000,000USD | 1,283,000,000USD | 2,659,000,000USD | 1,246,000,000USD | 1,082,000,000USD |
| Net Working Capital | 3,674,000,000USD | 3,738,000,000USD | 4,040,000,000USD | 1,664,000,000USD | 2,732,000,000USD | 1,808,000,000USD | 7,391,000,000USD | 27,000,000USD |
| Unclassified Current Assets | -22,482,000,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Assets | 2,818,000,000USD | -1,624,000,000USD | -1,525,000,000USD | -1,217,000,000USD | -4,849,000,000USD | -2,659,000,000USD | -1,236,000,000USD | -1,082,000,000USD |
| Unclassified Non Current Liabilities | 17,582,000,000USD | 1,422,000,000USD | 641,000,000USD | -2,483,000,000USD | -5,610,000,000USD | -2,956,000,000USD | -1,099,000,000USD | -1,164,000,000USD |
| Unclassified Equity | 11,335,000,000USD | 11,564,000,000USD | 14,447,000,000USD | 20,059,000,000USD | 19,671,000,000USD | 19,458,000,000USD | 7,647,000,000USD | — |
| Inventory | — | — | -35,184,000,000USD | — | — | — | — | — |
| Other Liab | — | — | — | 3,098,000,000USD | 7,017,000,000USD | 4,490,000,000USD | 1,099,000,000USD | 1,164,000,000USD |
| Treasury Stock | — | — | — | -4,213,000,000USD | -1,094,000,000USD | -816,000,000USD | -214,000,000USD | -139,000,000USD |
| Net Tangible Assets | — | — | — | -1,610,000,000USD | -800,000,000USD | -1,190,000,000USD | 3,658,000,000USD | 1,673,000,000USD |
| Unclassified Current Liabilities | — | — | — | — | -267,000,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 600,000,000USD |
| Stock Based Compensation | 126,000,000USD |
| Deferred Income Tax | -34,000,000USD |
| Other Non Cash Items | 1,000,000USD |
| Change To Liabilities | 5,411,000,000USD |
| Change In Working Capital | 3,761,000,000USD |
| Operating Cash Flow | 7,956,000,000USD |
| Capital Expenditures | -374,000,000USD |
| Net Investments | 110,000,000USD |
| Investing Cash Flow | -264,000,000USD |
| Net Debt Issuance | -1,304,000,000USD |
| Net Common Stock Issuance | -33,000,000USD |
| Other Financing Activities | -3,000,000USD |
| Unclassified Financing Cash Flow | 18,000,000USD |
| Financing Cash Flow | -1,322,000,000USD |
| Change In Cash | 6,370,000,000USD |
| End Cash Flow | 24,254,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,539,000,000USD | -1,101,000,000USD | -6,632,000,000USD | -259,000,000USD | 1,314,000,000USD | 275,000,000USD | 710,000,000USD | 1,146,000,000USD |
| Depreciation | 300,000,000USD | 1,275,000,000USD | 317,000,000USD | 315,000,000USD | 314,000,000USD | 314,000,000USD | 313,000,000USD | 306,000,000USD |
| Stock Based Compensation | 67,000,000USD | 58,000,000USD | 52,000,000USD | 35,000,000USD | 59,000,000USD | 31,000,000USD | 49,000,000USD | 62,000,000USD |
| Other Non Cash Items | 7,000,000USD | 815,000,000USD | 9,042,000,000USD | 66,000,000USD | 15,000,000USD | 6,000,000USD | 9,000,000USD | -14,000,000USD |
| Change To Account Receivables | -1,353,000,000USD | 4,818,000,000USD | -1,537,000,000USD | 883,000,000USD | -2,684,000,000USD | -1,596,000,000USD | -1,678,000,000USD | 152,000,000USD |
| Change In Working Capital | 1,740,000,000USD | 723,000,000USD | -1,552,000,000USD | 1,717,000,000USD | -165,000,000USD | -1,212,000,000USD | -2,033,000,000USD | 739,000,000USD |
| Total Cash From Operating Activities | 3,600,000,000USD | 437,000,000USD | 1,356,000,000USD | 1,785,000,000USD | 1,510,000,000USD | -587,000,000USD | -978,000,000USD | 2,175,000,000USD |
| Capital Expenditures | -200,000,000USD | -213,000,000USD | -211,000,000USD | -208,000,000USD | -135,000,000USD | -154,000,000USD | -153,000,000USD | -186,000,000USD |
| Free Cash Flow | 3,400,000,000USD | 224,000,000USD | 1,145,000,000USD | 1,577,000,000USD | 1,375,000,000USD | -741,000,000USD | -1,131,000,000USD | 1,989,000,000USD |
| Investments | 289,000,000USD | 873,000,000USD | 1,240,000,000USD | -899,000,000USD | -529,000,000USD | 102,000,000USD | -839,000,000USD | -1,167,000,000USD |
| Total Cashflows From Investing Activities | 89,000,000USD | 660,000,000USD | 1,221,000,000USD | -899,000,000USD | -529,000,000USD | 102,000,000USD | -839,000,000USD | -1,167,000,000USD |
| Net Borrowings | -1,046,000,000USD | -187,000,000USD | -1,000,000USD | -749,000,000USD | -208,000,000USD | 922,000,000USD | -29,000,000USD | — |
| Total Cash From Financing Activities | -1,063,000,000USD | -187,000,000USD | 9,000,000USD | -1,174,000,000USD | -250,000,000USD | -13,000,000USD | -1,245,000,000USD | -1,171,000,000USD |
| Sale Purchase Of Stock | -29,000,000USD | -2,000,000USD | -444,000,000USD | -432,000,000USD | -41,000,000USD | -943,000,000USD | -1,227,000,000USD | -803,000,000USD |
| Issuance Of Capital Stock | 10,000,000USD | 8,000,000USD | 11,000,000USD | 8,000,000USD | 10,000,000USD | 9,000,000USD | 12,000,000USD | 11,000,000USD |
| Change In Cash | 2,630,000,000USD | 830,000,000USD | 2,545,000,000USD | -302,000,000USD | 752,000,000USD | -514,000,000USD | -3,028,000,000USD | 20,000,000USD |
| Begin Period Cash Flow | 17,957,000,000USD | 17,058,000,000USD | 14,513,000,000USD | 14,815,000,000USD | 14,063,000,000USD | 14,577,000,000USD | 17,605,000,000USD | 17,585,000,000USD |
| End Period Cash Flow | 20,587,000,000USD | 17,888,000,000USD | 17,058,000,000USD | 14,513,000,000USD | 14,815,000,000USD | 14,063,000,000USD | 14,577,000,000USD | 17,605,000,000USD |
| Other Cashflows From Financing Activities | 2,000,000USD | -6,000,000USD | -1,000,000USD | -1,000,000USD | -11,000,000USD | -1,000,000USD | -1,000,000USD | -1,000,000USD |
| Unclassified Operating Cash Flow | -53,000,000USD | -1,333,000,000USD | 129,000,000USD | -89,000,000USD | -27,000,000USD | — | -26,000,000USD | -64,000,000USD |
| Other Cashflows From Investing Activities | — | 1,239,000,000USD | 366,000,000USD | -1,085,000,000USD | -394,000,000USD | -408,000,000USD | -664,000,000USD | -981,000,000USD |
| Unclassified Investing Cash Flow | — | -1,239,000,000USD | -174,000,000USD | 1,293,000,000USD | 529,000,000USD | 562,000,000USD | 817,000,000USD | 1,167,000,000USD |
| Unclassified Financing Cash Flow | — | 8,000,000USD | 455,000,000USD | — | 10,000,000USD | 9,000,000USD | — | -367,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6,677,000,000USD | 3,294,000,000USD | 2,702,000,000USD | 1,202,000,000USD | 1,336,000,000USD | 1,794,000,000USD | 1,309,000,000USD | 894,000,000USD |
| Depreciation | 1,275,000,000USD | 1,241,000,000USD | 1,293,000,000USD | 1,553,000,000USD | 1,476,000,000USD | 1,259,000,000USD | 643,000,000USD | 495,000,000USD |
| Stock Based Compensation | 204,000,000USD | 212,000,000USD | 216,000,000USD | 234,000,000USD | 203,000,000USD | 281,000,000USD | 177,000,000USD | 145,000,000USD |
| Other Non Cash Items | 9,523,000,000USD | -91,000,000USD | 546,000,000USD | 1,709,000,000USD | -54,000,000USD | 25,000,000USD | 301,000,000USD | 1,000,000,000USD |
| Change To Account Receivables | 1,480,000,000USD | -4,333,000,000USD | -2,380,000,000USD | -1,627,000,000USD | -2,453,000,000USD | -52,000,000USD | -1,076,000,000USD | -1,173,000,000USD |
| Change In Working Capital | 823,000,000USD | -4,515,000,000USD | 3,374,000,000USD | 2,194,000,000USD | 1,376,000,000USD | 2,195,000,000USD | -1,002,000,000USD | -171,000,000USD |
| Total Cash From Operating Activities | 5,088,000,000USD | 154,000,000USD | 8,053,000,000USD | 6,261,000,000USD | 4,205,000,000USD | 5,503,000,000USD | 1,483,000,000USD | 1,234,000,000USD |
| Capital Expenditures | -767,000,000USD | -644,000,000USD | -799,000,000USD | -1,004,000,000USD | -910,000,000USD | -869,000,000USD | -730,000,000USD | -675,000,000USD |
| Free Cash Flow | 4,321,000,000USD | -490,000,000USD | 7,254,000,000USD | 5,257,000,000USD | 3,295,000,000USD | 4,634,000,000USD | 753,000,000USD | 559,000,000USD |
| Investments | 1,239,000,000USD | -1,052,000,000USD | -21,000,000USD | -2,921,000,000USD | -3,299,000,000USD | -2,481,000,000USD | -766,000,000USD | -1,855,000,000USD |
| Total Cashflows From Investing Activities | 453,000,000USD | -1,052,000,000USD | -1,279,000,000USD | -2,921,000,000USD | -3,299,000,000USD | -6,955,000,000USD | -1,532,000,000USD | -4,585,000,000USD |
| Net Borrowings | -1,145,000,000USD | 678,000,000USD | 19,000,000USD | -1,144,000,000USD | 1,833,000,000USD | 839,000,000USD | 6,870,000,000USD | 1,969,000,000USD |
| Total Cash From Financing Activities | -1,602,000,000USD | -2,406,000,000USD | -1,570,000,000USD | -4,197,000,000USD | 1,362,000,000USD | 260,000,000USD | 6,811,000,000USD | 4,686,000,000USD |
| Sale Purchase Of Stock | -475,000,000USD | -3,124,000,000USD | -1,633,000,000USD | -3,096,000,000USD | -297,000,000USD | -626,000,000USD | -75,000,000USD | -71,000,000USD |
| Issuance Of Capital Stock | 37,000,000USD | 46,000,000USD | 40,000,000USD | 70,000,000USD | 35,000,000USD | 0USD | 0USD | 2,779,000,000USD |
| Change In Cash | 3,825,000,000USD | -3,130,000,000USD | 5,119,000,000USD | -1,044,000,000USD | 2,318,000,000USD | -1,323,000,000USD | 6,781,000,000USD | 1,270,000,000USD |
| Begin Period Cash Flow | 14,156,000,000USD | 17,193,000,000USD | 12,074,000,000USD | 13,118,000,000USD | 10,800,000,000USD | 12,123,000,000USD | 5,342,000,000USD | 4,072,000,000USD |
| End Period Cash Flow | 17,957,000,000USD | 14,063,000,000USD | 17,193,000,000USD | 12,074,000,000USD | 13,118,000,000USD | 10,800,000,000USD | 12,123,000,000USD | 5,342,000,000USD |
| Other Cashflows From Investing Activities | 1,239,000,000USD | 990,000,000USD | -392,000,000USD | -457,000,000USD | 19,000,000USD | -22,000,000USD | -766,000,000USD | -1,855,000,000USD |
| Other Cashflows From Financing Activities | -19,000,000USD | -6,000,000USD | -88,000,000USD | -41,000,000USD | -102,000,000USD | -34,000,000USD | 16,000,000USD | 9,000,000USD |
| Unclassified Operating Cash Flow | -60,000,000USD | 13,000,000USD | — | -631,000,000USD | -132,000,000USD | — | 55,000,000USD | -1,129,000,000USD |
| Unclassified Investing Cash Flow | -1,258,000,000USD | -346,000,000USD | -67,000,000USD | 1,461,000,000USD | 891,000,000USD | -3,583,000,000USD | 730,000,000USD | -200,000,000USD |
| Unclassified Financing Cash Flow | 37,000,000USD | 46,000,000USD | 220,000,000USD | 84,000,000USD | -37,000,000USD | 81,000,000USD | — | 8,856,000,000USD |
| Change To Inventory | — | — | 2,122,000,000USD | — | -1,141,000,000USD | -585,000,000USD | 421,000,000USD | 1,545,000,000USD |
| Dividends Paid | — | — | -88,000,000USD | — | -35,000,000USD | — | — | -6,077,000,000USD |
| Change To Liabilities | — | — | — | 3,660,000,000USD | 1,032,000,000USD | 2,780,000,000USD | 342,000,000USD | 1,050,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -857,000,000USD | 2,268,000,000USD | -1,192,000,000USD | 6,783,000,000USD | 1,261,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Health Care Premium | 43,582,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Services | 793,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | All Other Segments | 1,196,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Commercial | 9,356,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Medicaid | 31,970,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Medicare | 11,057,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Premium | 43,887,000,000 | USD | 0001071739-26-000098 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 768,000,000 | USD | 0001071739-26-000098 |
| Q1 2026Quarterly · 2026-03-31 | Segment | All Other Segments | 1,177,000,000 | USD | 0001071739-26-000098 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Commercial | 9,556,000,000 | USD | 0001071739-26-000098 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Medicaid | 28,885,000,000 | USD | 0001071739-26-000098 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Medicare | 10,326,000,000 | USD | 0001071739-26-000098 |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care Premium | 43,978,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Services | 749,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | All Other Segments | 1,280,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Commercial | 10,792,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Medicaid | 28,043,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Medicare | 9,610,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Health Care Premium | 171,556,000,000 | USD | 0001071739-26-000049 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 3,025,000,000 | USD | 0001071739-26-000049 |
| FY 2025Yearly · 2025-12-31 | Segment | All Other Segments | 5,130,000,000 | USD | 0001071739-26-000049 |
| FY 2025Yearly · 2025-12-31 | Segment | Commercial | 42,003,000,000 | USD | 0001071739-26-000049 |
| FY 2025Yearly · 2025-12-31 | Segment | Medicaid | 110,434,000,000 | USD | 0001071739-26-000049 |
| FY 2025Yearly · 2025-12-31 | Segment | Medicare | 37,210,000,000 | USD | 0001071739-26-000049 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care Premium | 44,126,000,000 | USD | 0001071739-25-000183 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 772,000,000 | USD | 0001071739-25-000183 |
| Q3 2025Quarterly · 2025-09-30 | Segment | All Other Segments | 1,344,000,000 | USD | 0001071739-25-000183 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Commercial | 10,992,000,000 | USD | 0001071739-25-000183 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Medicaid | 27,963,000,000 | USD | 0001071739-25-000183 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Medicare | 9,391,000,000 | USD | 0001071739-25-000183 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care Premium | 41,740,000,000 | USD | 0001071739-25-000150 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 727,000,000 | USD | 0001071739-25-000150 |
| Q2 2025Quarterly · 2025-06-30 | Segment | All Other Segments | 1,224,000,000 | USD | 0001071739-25-000150 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Commercial | 10,070,000,000 | USD | 0001071739-25-000150 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Medicaid | 27,998,000,000 | USD | 0001071739-25-000150 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Medicare | 9,450,000,000 | USD | 0001071739-25-000150 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Premium | 41,712,000,000 | USD | 0001071739-26-000098 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 777,000,000 | USD | 0001071739-26-000098 |
| Q1 2025Quarterly · 2025-03-31 | Segment | All Other Segments | 1,282,000,000 | USD | 0001071739-26-000098 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Commercial | 10,149,000,000 | USD | 0001071739-26-000098 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Medicaid | 26,430,000,000 | USD | 0001071739-26-000098 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Medicare | 8,759,000,000 | USD | 0001071739-26-000098 |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care Premium | 35,519,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 777,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | All Other Segments | 1,272,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Commercial | 8,723,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Medicaid | 25,334,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Medicare | 5,476,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Health Care Premium | 142,303,000,000 | USD | 0001071739-26-000049 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 3,202,000,000 | USD | 0001071739-26-000049 |
| FY 2024Yearly · 2024-12-31 | Segment | All Other Segments | 4,920,000,000 | USD | 0001071739-26-000049 |
| FY 2024Yearly · 2024-12-31 | Segment | Commercial | 33,702,000,000 | USD | 0001071739-26-000049 |
| FY 2024Yearly · 2024-12-31 | Segment | Medicaid | 101,417,000,000 | USD | 0001071739-26-000049 |
| FY 2024Yearly · 2024-12-31 | Segment | Medicare | 23,032,000,000 | USD | 0001071739-26-000049 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care Premium | 36,115,000,000 | USD | 0001071739-25-000183 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 784,000,000 | USD | 0001071739-25-000183 |
| Q3 2024Quarterly · 2024-09-30 | Segment | All Other Segments | 1,247,000,000 | USD | 0001071739-25-000183 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Commercial | 8,693,000,000 | USD | 0001071739-25-000183 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Medicaid | 26,440,000,000 | USD | 0001071739-25-000183 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Medicare | 5,643,000,000 | USD | 0001071739-25-000183 |
| FY 2023Yearly · 2023-12-31 | Product | Health Care Premium | 135,636,000,000 | USD | 0001071739-26-000049 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 4,459,000,000 | USD | 0001071739-26-000049 |
| FY 2023Yearly · 2023-12-31 | Segment | All Other Segments | 6,134,000,000 | USD | 0001071739-26-000049 |
| FY 2023Yearly · 2023-12-31 | Segment | Commercial | 24,845,000,000 | USD | 0001071739-26-000049 |
| FY 2023Yearly · 2023-12-31 | Segment | Medicaid | 100,759,000,000 | USD | 0001071739-26-000049 |
| FY 2023Yearly · 2023-12-31 | Segment | Medicare | 22,261,000,000 | USD | 0001071739-26-000049 |
| FY 2022Yearly · 2022-12-31 | Product | Health Care Premium | 127,131,000,000 | USD | 0001071739-25-000027 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 8,348,000,000 | USD | 0001071739-25-000027 |
| FY 2022Yearly · 2022-12-31 | Segment | All Other Segments | 11,532,000,000 | USD | 0001071739-25-000027 |
| FY 2022Yearly · 2022-12-31 | Segment | Commercial | 17,380,000,000 | USD | 0001071739-25-000027 |
| FY 2022Yearly · 2022-12-31 | Segment | Medicaid | 93,151,000,000 | USD | 0001071739-25-000027 |
| FY 2022Yearly · 2022-12-31 | Segment | Medicare | 22,484,000,000 | USD | 0001071739-25-000027 |
| FY 2021Yearly · 2021-12-31 | Product | Health Care Premium | 112,319,000,000 | USD | 0001071739-24-000037 |
| FY 2021Yearly · 2021-12-31 | Product | Services | 5,664,000,000 | USD | 0001071739-24-000037 |
| FY 2021Yearly · 2021-12-31 | Segment | All Other Segments | 7,375,000,000 | USD | 0001071739-24-000037 |
| FY 2021Yearly · 2021-12-31 | Segment | Commercial | 16,956,000,000 | USD | 0001071739-24-000037 |
| FY 2021Yearly · 2021-12-31 | Segment | Medicaid | 84,139,000,000 | USD | 0001071739-24-000037 |
| FY 2021Yearly · 2021-12-31 | Segment | Medicare | 17,512,000,000 | USD | 0001071739-24-000037 |
| FY 2020Yearly · 2020-12-31 | Product | Health Care Premium | 100,055,000,000 | USD | 0001071739-23-000047 |
| FY 2020Yearly · 2020-12-31 | Product | Services | 3,745,000,000 | USD | 0001071739-23-000047 |
| FY 2019Yearly · 2019-12-31 | Product | Health Care Premium | 67,439,000,000 | USD | 0001071739-22-000071 |
| FY 2019Yearly · 2019-12-31 | Product | Services | 2,925,000,000 | USD | 0001071739-22-000071 |
| FY 2018Yearly · 2018-12-31 | Product | Health Care Premium | 53,629,000,000 | USD | 0001071739-21-000039 |
| FY 2018Yearly · 2018-12-31 | Product | Services | 2,806,000,000 | USD | 0001071739-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Managed Care | 56,999,000,000 | USD | 0001071739-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Specialty Services | 3,117,000,000 | USD | 0001071739-21-000039 |
| FY 2017Yearly · 2017-12-31 | Segment | Managed Care | 45,798,000,000 | USD | 0001071739-20-000060 |
| FY 2017Yearly · 2017-12-31 | Segment | Specialty Services | 2,584,000,000 | USD | 0001071739-20-000060 |
| FY 2016Yearly · 2016-12-31 | Segment | Managed Care | 38,182,000,000 | USD | 0001071739-19-000032 |
| FY 2016Yearly · 2016-12-31 | Segment | Specialty Services | 2,425,000,000 | USD | 0001071739-19-000032 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.